BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Mesalamine
1
Reevaluating aminosalicylates role in maintaining remission in ulcerative colitis: Systematic review and meta-analysis in the era of biologics
12/18/2025 5:53:46 AM | Browse: 43 | Download: 152
2
Shared decision-making improves adherence to mesalamine in ulcerative colitis: A prospective, multicenter, non-interventional cohort study in Germany
6/12/2025 3:45:51 AM | Browse: 195 | Download: 671
3
Ulcerative colitis and bullous pemphigoid - a direct association or a medication side effect: A case report
12/12/2024 7:29:57 AM | Browse: 109 | Download: 651
4
Delayed-release oral mesalamine tablet mimicking a small jejunal gastrointestinal stromal tumor: A case report
6/24/2022 9:00:25 AM | Browse: 516 | Download: 1301
5
Diagnosis of acute intermittent porphyria in a renal transplant patient: A case report
1/12/2022 7:13:00 AM | Browse: 594 | Download: 1334
6
Nonasthmatic eosinophilic bronchitis in an ulcerative colitis patient – a putative adverse reaction to mesalazine: A case report and review of literature
9/22/2020 3:17:14 AM | Browse: 894 | Download: 1933
7
Conventional therapy for moderate to severe inflammatory bowel disease: A systematic literature review
3/7/2019 3:51:24 AM | Browse: 1340 | Download: 2140
8
Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
5/4/2017 8:16:34 AM | Browse: 1555 | Download: 3098
9
Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal?
11/12/2015 7:10:00 PM | Browse: 1642 | Download: 2579
10
Isolated fever induced by mesalamine treatment
9/16/2014 4:56:00 PM | Browse: 1516 | Download: 1812
11
Noninfectious interstitial lung disease during infliximab therapy: Case report and literature review
9/15/2014 8:53:00 PM | Browse: 1213 | Download: 1395
Write to the Help Desk
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345